Abstract
Background Portal vein thrombosis (PVT) represents a potentially unfavorable prognostic factor in liver transplantation (LT) for hepatocellular carcinoma (HCC). However, it is frequently difficult to establish preoperatively whether the thrombus is associated with tumor invasion or with stagnant flow. The purpose of this study was to further address this controversial issue. Patients and methods We evaluated 12 consecutive patients who underwent liver transplantation for HCC in the setting of PVT. Results The origin of PVT in HCC patients could be accurately evaluated in 58% of the patients. Forty-two percent of patients had no evident portal vein invasion and only 17% of cases had tumor thrombi. One-third of patients experienced tumor recurrence within the first posttransplant year, and one-third of patients became long-term survivors (median survival of 36 months) with no evidence of tumor recurrence. One-year survival was 92%. Nine patients are currently alive after a median follow-up period of 25 months. Conclusions PVT in the setting of HCC is characterized by poor patient outcome. However, a respectable number of instances are not accurately evaluated preoperatively, making the decision to exclude these patients from LT sometimes a challenging dilemma.
Similar content being viewed by others
Abbreviations
- AFP:
-
Alpha fetoprotein
- CTM:
-
Cirrhosis-related thrombotic material
- DDLT:
-
Deceased donor full-size liver transplantation
- HCC:
-
Hepatocellular carcinoma
- LDLT:
-
Live donor liver transplantation
- LT:
-
Liver transplantation
- MELD:
-
Model for end stage liver disease
- NTM:
-
No thrombotic material
- PVT:
-
Portal vein thrombosis
- PVTT:
-
Portal vein tumor thrombi
- RFA:
-
Radio-frequency ablation
- SLT:
-
Deceased donor split liver transplantation
- TACE:
-
Transarterial chemoembolization
- TTM:
-
Tumor-related thrombotic material
- UICC:
-
Union International Contre le Cancer
References
Mazzaferro V, Regalia E, Doci R et al (1996) Liver transplantation for the treatment of small hepatocellular carcinomas in patients with cirrhosis. N Engl J Med 334:693–699
Llovet JM, Bruix J, Fuster J et al (1998) Liver transplantation for small hepatocellular carcinoma: the tumor-node-metastasis classification does not have prognostic power. Hepatology 27:1572–1577
Bismuth H, Majno PE, Adam R (1999) Liver transplantation for hepatocellular carcinoma. Semin Liver Dis 19:311–322
De Carlis L, Giacomoni A, Lauterio A et al (2003) Liver transplantation for hepatocellular cancer: should the current indication criteria be changed? Transpl Int 16:115–122
Kaihara S, Kiuchi T, Ueda M et al (2003) Living-donor liver transplantation for hepatocellular carcinoma. Transplantation 75:S37–S40
Malago M, Sotiropoulos GC, Nadalin S et al (2006) Living donor liver transplantation for hepatocellular carcinoma: a single-center preliminary report. Liver Transpl 12:934–940
Akahane M, Koga H, Kato N et al (2005) Complications of percutaneous radiofrequency ablation for hepatocellular carcinoma: imaging spectrum and management. Radiographics 25:S57–S68
Amitrano L, Brancaccio V, Guardascione MA et al (2000) Inherited coagulation disorders in cirrhotic patients with portal vein thrombosis. Hepatology 31:345–348
Sotiropoulos GC, Malago M, Molmenti E et al (2005) Liver transplantation for hepatocellular carcinoma in cirrhosis: is clinical tumor classification before transplantation realistic? Transplantation 79:483–487
Sotiropoulos GC, Paul A, Molmenti E et al (2005) Liver transplantation for hepatocellular carcinoma in cirrhosis within the Eurotransplant area: an additional option with “livers that nobody wants”. Transplantation 80:897–902
Sotiropoulos GC, Paul A, Gerling T et al (2006) Liver transplantation with “rescue organ offers” within the eurotransplant area: a 2-year report from the University Hospital Essen. Transplantation 82:304–309
Greene FL, Page DL, Fleming ID et al (2002) AJCC cancer staging manual, 6th edn. Springer, New York, p 131
Bruix J, Sherman M, Llovet JM et al (2001) Clinical management of hepatocellular carcinoma. Conclusions of the Barcelona-2000 EASL conference. European Association for the Study of the Liver. J Hepatol 35:421–430
Nonami T, Yokoyama I, Iwatsuki S, Starzl TE (1992) The incidence of portal vein thrombosis at liver transplantation. Hepatology 16:1195–1198
Robles R, Fernandez JA, Hernandez Q et al (2003) Eversion thromboendovenectomy for organized portal vein thrombosis encountered during liver transplantation. Transplant Proc 35:1915–1917
Azoulay D, Hargreaves GM, Castaing D, Bismuth H (2000) Caval inflow to the graft: a successful way to overcome diffuse portal system thrombosis in liver transplantation. J Am Coll Surg 190:493–496
Norrby J, Mjornstedt L, Liden H et al (2001) Liver transplantation using cavoportal hemitransposition: a possibility in the presence of extensive portal vein thrombosis. Transplant Proc 33:2495–2496
Paskonis M, Jurgaitis J, Mehrabi A et al (2006) Surgical strategies for liver transplantation in the case of portal vein thrombosis—current role of cavoportal hemitransposition and renoportal anastomosis. Clin Transplant 20:551–562
Cherqui D, Duvoux C, Rahmouni A et al (1993) Orthotopic liver transplantation in the presence of partial or total portal vein thrombosis: problems in diagnosis and management. World J Surg 17:669–674
Dumortier J, Czyglik O, Poncet G et al (2002) Eversion thrombectomy for portal vein thrombosis during liver transplantation. Am J Transplant 2:934–938
Xu X, Zheng SS, Liang TB et al (2004) Orthotopic liver transplantation for patients with hepatocellular carcinoma complicated by portal vein tumor thrombi. Hepatobiliary Pancreat Dis Int 3:341–344
Chen XP, Huang ZY (2005) Surgical treatment of hepatocellular carcinoma in China: surgical techniques, indications, and outcomes. Langenbecks Arch Surg 390:259–265
Wu FS, Zhao WH, Liang TB et al (2005) Survival factors after resection of small hepatocellular carcinoma. Hepatobiliary Pancreat Dis Int 4:379–384
Fan J, Wu ZQ, Tang ZY et al (2001) Multimodality treatment in hepatocellular carcinoma patients with tumor thrombi in portal vein. World J Gastroenterol 7:28–32
Wu CC, Hsieh SR, Chen JT et al (2000) An appraisal of liver and portal vein resection for hepatocellular carcinoma with tumor thrombi extending to portal bifurcation. Arch Surg 135:1273–1279
Capussotti L, Muratore A, Massucco P et al (2004) Major liver resections for hepatocellular carcinoma on cirrhosis: early and long-term outcomes. Liver Transpl 10:S64–S68
Chen XP, Qiu FZ, Wu ZD et al (2006) Effects of location and extension of portal vein tumor thrombus on long-term outcomes of surgical treatment for hepatocellular carcinoma. Ann Surg Oncol 13:940–946
Ikai I, Hatano E, Hasegawa S et al (2006) Prognostic index for patients with hepatocellular carcinoma combined with tumor thrombosis in the major portal vein. J Am Coll Surg 202:431–438
Fan J, Zhou J, Wu ZQ et al (2005) Efficacy of different treatment strategies for hepatocellular carcinoma with portal vein tumor thrombosis. World J Gastroenterol 11:1215–1219
Hata M, Tokuuye K, Sugahara S et al (2005) Proton beam therapy for hepatocellular carcinoma with portal vein tumor thrombus. Cancer 104:794–801
Ando E, Tanaka M, Yamashita F et al (2002) Hepatic arterial infusion chemotherapy for advanced hepatocellular carcinoma with portal vein tumor thrombosis: analysis of 48 cases. Cancer 95:588–595
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Sotiropoulos, G.C., Radtke, A., Schmitz, K.J. et al. Liver Transplantation in the Setting of Hepatocellular Carcinoma and Portal Vein Thrombosis: A Challenging Dilemma?. Dig Dis Sci 53, 1994–1999 (2008). https://doi.org/10.1007/s10620-007-0099-4
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10620-007-0099-4